News Releases

Anixa Biosciences Announces Collaboration with Idaho Urologic Institute on Cchek™ Prostate Cancer Study

November 20, 2019

Anixa Biosciences Announces Presentation at Cell Symposia: Hallmarks of Cancer

November 7, 2019

Anixa Biosciences Announces Patent Issued for its Breast Cancer Vaccine

November 5, 2019

Anixa Biosciences Names Novartis Executive Dr. Emanuele Ostuni to Scientific Advisory Board

October 28, 2019

Anixa Biosciences Announces Collaboration with Urology San Antonio on Cchek™ Prostate Cancer Study

October 25, 2019

Anixa Biosciences Announces Abstract Accepted for Presentation at the 34th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2019)

October 22, 2019

Anixa Biosciences Appoints Dr. Thomas Schlumpberger as Executive Vice President of Diagnostics to Head Liquid Biopsy Development and Commercialization Efforts

October 15, 2019

Anixa Biosciences Names Cancer Vaccine Pioneer Dr. Ian H. Frazer to Scientific Advisory Board

October 10, 2019

Anixa Biosciences Announces University of Maryland School of Medicine to Join Cchek™ Prostate Cancer Study

September 23, 2019

Anixa Biosciences Commences Collaboration with Potomac Urology Center on Cchek™ Prostate Cancer Study

September 19, 2019

« Previous
1
2
3
4
5
6
7
8
9
10
...15
Next »

Latest News & Events

Mar 2, 2020

Anixa Biosciences Announces Presentation at AI and Big Data in Cancer Conference

Read More...

Feb 12, 2020

Anixa Biosciences and Moffitt Cancer Center Announce Completion of Viral Vector Reformulation for CAR-T Program

Read More...

Jan 6, 2020

Anixa Biosciences Announces Presentation at AACR Liquid Biopsies Conference

Read More...

Cancer of the Lung, Breast, Colon, Prostate, and Stomach are the five most prevalent cancers worldwide.